written on 13.06.2014

NYT: Goldman Sachs caught in the middle of Valeant, Allergan takeover fight


Goldman Sachs has a reputation for helping its clients ward off hostile takeover attempts. But since Allergan brought the firm on to defend against Valeant&#39;s unsolicited bid, Goldman&#39;s been rather quiet–prior involvement with Valeant may have something to do with it, <em>The New York Times</em> reports.